SynthesisCardiorenal medicine2025

Cardiovascular and Kidney Outcomes of Glucagon-Like Peptide 1 Receptor Agonist Therapy in Type 2 Diabetes Mellitus and Chronic Kidney Disease: A Systematic Review and Meta-Analysis.

Nicole Felix et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.